|
Name |
3-Ethoxypropionic acid
|
Molecular Formula | C5H10O3 | |
IUPAC Name* |
3-ethoxypropanoic acid
|
|
SMILES |
CCOCCC(=O)O
|
|
InChI |
InChI=1S/C5H10O3/c1-2-8-4-3-5(6)7/h2-4H2,1H3,(H,6,7)
|
|
InChIKey |
JRXXEXVXTFEBIY-UHFFFAOYSA-N
|
|
Synonyms |
3-Ethoxypropanoic acid; 3-Ethoxypropionic acid; 4324-38-3; PROPANOIC ACID, 3-ETHOXY-; 1331-11-9; NSC-8118; Ethoxypropionic acid; Propionic acid, ethoxy-; 3-Ethoxypropionicacid; 3-ethoxy-propionic acid; EINECS 224-357-9; 3-Ethoxypropanoicacid; O-Ethylhydracrylic Acid; AI3-52370; 3-Ethoxypropanoic acid #; .beta.-Ethoxypropionic acid; SCHEMBL27523; JRXXEXVXTFEBIY-UHFFFAOYSA-; DTXSID70863366; NSC8118; ACT03023; ALBB-022360; NSC 8118; NSC16879; ZINC1586414; MFCD00058997; NSC 16879; NSC-16879; AKOS000183015; FS-4045; CS-0216898; E0053; FT-0714471; EN300-64537; F11739; A872727; Z316258938
|
|
CAS | 4324-38-3 | |
PubChem CID | 61351 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 118.13 | ALogp: | -0.1 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 0 |
Heavy Atoms: | 8 | QED Weighted: | 0.558 |
Caco-2 Permeability: | -5.159 | MDCK Permeability: | 0.00025975 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.687 | Plasma Protein Binding (PPB): | 14.01% |
Volume Distribution (VD): | 0.252 | Fu: | 73.88% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.115 |
CYP2C19-inhibitor: | 0.025 | CYP2C19-substrate: | 0.064 |
CYP2C9-inhibitor: | 0.003 | CYP2C9-substrate: | 0.654 |
CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.186 |
CYP3A4-inhibitor: | 0.01 | CYP3A4-substrate: | 0.027 |
Clearance (CL): | 7.553 | Half-life (T1/2): | 0.859 |
hERG Blockers: | 0.018 | Human Hepatotoxicity (H-HT): | 0.053 |
Drug-inuced Liver Injury (DILI): | 0.054 | AMES Toxicity: | 0.079 |
Rat Oral Acute Toxicity: | 0.015 | Maximum Recommended Daily Dose: | 0.02 |
Skin Sensitization: | 0.225 | Carcinogencity: | 0.153 |
Eye Corrosion: | 0.959 | Eye Irritation: | 0.988 |
Respiratory Toxicity: | 0.036 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000018 | 0.500 | D0EP8X | 0.393 | ||||
ENC000315 | 0.448 | D0Y7ZD | 0.333 | ||||
ENC000058 | 0.391 | D0O4GY | 0.324 | ||||
ENC000677 | 0.385 | D0FD0H | 0.324 | ||||
ENC000735 | 0.375 | D06VNK | 0.323 | ||||
ENC000030 | 0.371 | D0R3QY | 0.294 | ||||
ENC000445 | 0.367 | D0M8AB | 0.280 | ||||
ENC000226 | 0.355 | D00ENY | 0.278 | ||||
ENC000639 | 0.345 | D0Y3KG | 0.270 | ||||
ENC000776 | 0.344 | D04CRL | 0.261 |